Exchange: NYSE·Updated 07:56 PM EST

RVTY News

News
all
press releases
Revvity Inc. (NYSE:RVTY) Stock Has Consensus Price Target of $136.71 According to Brokerages
Revvity Inc. (NYSE:RVTY - Get Free Report) has been assigned an average rating of "Hold" from the nineteen analysts that are covering the company, MarketBeat Ratings reports. Thirteen research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the com...
MarketBeat
Revvity Inc. (NYSE:RVTY) Stock Has Consensus Price Target of $136.71 According to Brokerages
Revvity Inc. (NYSE:RVTY - Get Free Report) has been assigned an average rating of "Hold" from the nineteen analysts that are covering the company, MarketBeat Ratings reports. Thirteen research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the com...
MarketBeat
More News
Revvity, Inc. (RVTY) Analyst/Investor Day - Slideshow...
SeekingAlpha
Revvity, Inc. (RVTY) Presents at Jefferies Global Healthcare Conference 2026 Transcript...
SeekingAlpha
Revvity (NYSE:RVTY) Share Price Breaks Below 50 Day Moving Average - Here's Why...
MarketBeat
JPMorgan Chase & Co. upped their target price on shares of Revvity from $160.00 to $165.00 and gave the company a "neutral" rating in a research report on Monday...
MarketBeat
Aberdeen Group plc grew its stake in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 6,958.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 345,100 shares of the company's stock after purchasing an addi...
MarketBeat
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content UpdatePR NewswireNEW YORK, Nov. 13, 2026 NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Nov. 13, 2026 /PRNewswire/ -- The New York Stock...
PR Newswire
Revvity, Inc. (NYSE: RVTY) today will host its 2026 Investor Day, highlighting the Company's differentiated portfolio of Life Sciences and Diagnostics solutions, as well as its position at the intersection of biology, experimentation and data. Under the theme "Powering Scientific Intelligence...
Business Wire
ELV vs. RVTY: Which Stock Is the Better Value Option?
Zacks
Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks

Advertisement|Remove ads.